EarningsQ2 2026 Earnings Report
MX:CE Q2 2026 EPS Results
Actual EPS$41.64
Consensus EPS$37.90
Beat/MissBeat by +$3.74
One Year Ago EPS$24.47
MX:CE Q2 2026 Revenue Results
Actual Revenue$46.77B
Expected Revenue$46.66B
Beat/MissBeat by +$110.93M
YoY Revenue Growth+8.69%
Earnings Announcement Details
QuarterQ2 2026
Date08/04/2026
TimeAfter Close
Conference CallTuesday, August 4, 2026
MX:CE Upcoming Earnings
Celanese's next earnings date is estimated for November 9, 2026, based on past reporting schedules.
Q2 2026 Earnings Call Audio
MX:CE Q2 2026 Earnings Call
0:00 / 0:00
Q2 2026 Earnings Slide Deck
Q2 2026 Earnings Call Summary
Earnings Call Sentiment|Positive
The call highlighted meaningful operational resilience: strong pricing execution in Engineered Materials, maintained free cash flow guidance ($700–800M baseline), decisive footprint and cost actions (nylon optimization and Lanaken closure), progress on divestitures and a clear deleveraging path. Offsetting these positives are near-term headwinds including raw material-driven margin compression expected in Q3, notable working capital and inventory absorption impacts (H1 working capital use ~$300M YTD), one-time divestiture and equity-earnings hits (~$35M Micromax, ~$10M Ibn Sina), and elevated corporate costs. Overall, the company preserved guidance and laid out credible multi-year actions to improve margins, cash flow, and leverage, but several material near-term puts-and-takes make H2 results sensitive to commodity and working-capital dynamics.Company Guidance
Engineered Materials pricing and margin expansion
Company executed aggressive price increases in late Q2 that drove margin expansion in Engineered Materials (EM); management expects EM adjusted EBIT to grow in the double-digits for 2026 (closer to ~15%) despite headwinds. Pricing actions positioned the business to offset a portion of rising raw material costs.
Free cash flow guidance and near-term cash generation
Management reiterated a sustainable free cash flow baseline of $700 million to $800 million for 2026. Reported roughly $140 million of free cash flow in the second quarter despite a near-term working capital build.
Progress on divestitures and deleveraging
Maintained $1.0 billion divestiture target by end of 2027 and is ~50% complete after closing Micromax. Expect to announce at least one deal by year-end. Net debt expected to finish 2026 around $10 billion and ~ $9 billion for 2027; long-term leverage target ~3x (near-term objective to reach 4x).
Operational agility — rapid restart of Frankfurt asset
Frankfurt plant was brought back into service in ~5 weeks after being down for over six months, demonstrating operational flexibility and ability to respond to supply dislocations to support reliability of supply.
Footprint and cost actions delivering structural savings
Ongoing footprint optimization expected to produce multi-year cost benefits: nylon optimization (~$30–35 million annualized) and Lanaken closure (~$20–25 million annualized). Management expects to capture portions of these savings in 2026 (roughly ~1/3 of Lanaken and ~1/2 of nylon savings) with the remainder in 2027.
Strategic mix enrichment in high-value EM subsegments
Focused penetration into higher-margin subsegments: electronics (~10% of EM revenue but ~10–15% of contribution margin) and medical (<10% of EM revenue but ~20% of contribution margin). Identified TAMs such as drug delivery/GLP-1 and data center/server applications (company-cited $500M GLP-1 TAM) to drive value-over-volume growth.
Guidance maintained with Q3 and full-year framework
Q3 EPS guide range of $1.35 to $1.75 was provided and management continues to target the previously-issued ~$6 full-year framework (the May $6 guide remains the reference point).
Ibn Sina joint venture resumption
Ibn Sina JV plant resumed operations in Q3, leading management to expect improved equity earnings and a higher level of dividends into Q4 after a period of disruption that impacted Q2 results.
MX:CE Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed